Baxter settles FDA warning letter over problems at 3 overseas plants

10/21/2011 | Reuters

Baxter International has settled an FDA warning letter it received in January over concerns that it violated good manufacturing practice standards and failed to file post-market reports at its two facilities in Puerto Rico. The company also resolved safety issues related to peritoneal dialysis solutions manufactured at its facility in Ireland.

View Full Article in:


Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA